Login / Signup

Risk of systemic vasculitis following mRNA COVID-19 vaccination: a pharmacovigilance study.

Camille MettlerBenjamin TerrierJean Marc TreluyerLaurent Chouchana
Published in: Rheumatology (Oxford, England) (2022)
Keyphrases
  • coronavirus disease
  • sars cov
  • emergency department
  • adverse drug